Importance Neonatal abstinence syndrome, which occurs as a result of in utero opioid
exposure, affects between 6.0 and 20 newborns per 1000 live US births. There is substantial …

Importance Rising incidence of neonatal abstinence syndrome (NAS) is straining perinatal
care systems. Newborns with NAS traditionally receive care in neonatal intensive care units …

Importance Substantial increases in both neonatal abstinence syndrome (NAS) and
maternal opioid use disorder have been observed through 2014. Objective To examine …

OBJECTIVES: To describe incidence, health care use, and cost trends for infants with
neonatal abstinence syndrome (NAS) who are covered by Medicaid compared with other …

The rates of opioid use disorder during pregnancy have more than quadrupled in the last
decade, resulting in numerous infants suffering exposure to opioids during the perinatal …

Opioid-induced respiratory depression (OIRD), the primary cause of opioid-induced death, is
the neural depression of respiratory drive which, together with a decreased level of …

Over time, the definition of “women's health” has expanded far beyond just reproductive
health, now including critical issues such as musculoskeletal conditions, pain, opioid use …

Objectives: Identify the etiology and epidemiology of neonatal abstinence syndrome.
Describe the typical presentation, evaluation options, and assessment tools for neonatal …

The past decade has seen a drastic rise in the number of infants exposed to opioids in utero.
It is unclear what lasting effect this exposure may have on these children. Animal models of …

Objectives. To examine the extent to which differences in medication for opioid use disorder
(MOUD) in pregnancy and infant neonatal opioid withdrawal syndrome (NOWS) outcomes …